Law360 (May 3, 2018, 3:54 PM EDT) — Patent suits involving generic drugs increased 29 percent in 2017 over the previous year, with a hefty 60 … The legal analytics firm’s annual report on litigation involving Abbreviated New Drug Applications under the Hatch-Waxman Act found that 417 ANDA suits …
